Sacubitril-valsartan has shown significant promise in patients with Heart Failure with reduced Ejection Fraction (HFrEF). We compared the safety of the sacubitril-valsartan with enalapril in patients with HFrEF. A comprehensive… Click to show full abstract
Sacubitril-valsartan has shown significant promise in patients with Heart Failure with reduced Ejection Fraction (HFrEF). We compared the safety of the sacubitril-valsartan with enalapril in patients with HFrEF. A comprehensive search was performed on PubMed, Embase, and Cochrane for randomized
               
Click one of the above tabs to view related content.